Undiagnosed diabetes and impaired glucose metabolism on high-risk Spanish population. The IGT study;Diabetes ignorada y otras alteraciones del metabolismo glucídico en la población española de alto riesgo. El estudio ITG

Medicina Clinica

Volumn 114, Issue 16, 2000, Pages 601-608

  Costa, Bernardo ^a,b   Martín, Francisco ^a   Donado, Ángel ^a   Parera, Francesca ^a   Piñol, José Luis ^a   Basora, Josep ^a   Daniel, Jordi ^a  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b Consulta de Diabetes Salou ^*  (Spain)

Author keywords

Diabetes; Diagnosis; Impaired fasting glucose; Impaired glucose tolerance; Screening

Indexed keywords

GLUCOSE;

ARTICLE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PRACTICE GUIDELINE; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SPAIN;

BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; GUIDELINES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 0034728750     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(00)71376-5     Document Type: Article

References (39)

1. Zimmet PZ. Diabetes epidemiology as a tool to trigger diabetes research and care. Diabetologia 1999; 42: 499-518.
2. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR. Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults. The third national health and nutntiton examination survey. 1988-1994. Diabetes Care 1998; 21: 518-524.
3. World Health Organization. WHO Study Group. Diabetes melitus. Technical report series 727. Ginebra: OMS, 1985.
4. American Diabetes Association. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
5. Castell C, Tresserras R, Serra J, Goday A, Lloveras G, Salleras L. Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study. Diab Res Clin Pract 1999; 43: 33-40.
6. Costa B, Franch J, Martin F, Morató J, Donado A, Basora J, IGT Research Group. Impact of the American Diabetes Association Diagnosis Criteria on High-Risk Spanish Population. Diab Res Clin Pract 1999; 46: 75-81.
7. Perry RC, Baron AD. Impaired glucose tolerance. Why is it not a disease? Diabetes Care 1999; 22: 883-885.
8. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX et al. Effect of diet and exercice in preventing NIDDM in people with impaired glucose tolerance: The Da Quing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-544.
9. Eriksson J, Lindström J, Valle T, Aunola S, Hämäläinen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Diabetologia 1999; 42: 793-801.
10. Chiasson JL, Gomis R, Hanefeld M, Josse RG, Karasik A, Laakso M. The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus. Diabetes Care 1998; 21: 1720-1725.
11. Costa B, Martín F, Donado A, Ricart I, Pedret R, Daniel J y el Grupo de Investigación sobre Intolerancia a la Glucosa. Detección selective de intolerancia a la glucosa y diabetes en atención primaria. El Estudio ITG-Reus (Taragona). Aten Primaria 1998; 22: 71-78.
12. Bayo J, Sola C, García F, Latorre PM, Vázquez JA. Prevalencia de la diabetes mellitus no dependiente de la insulina en Lejona (Vizcaya) Med Clin (Barc) 1993; 101: 609-612.
13. Franch J, Álvarez JC, Álvarez F, Diego F, Hernández R, Cueto A. Epidemiología de la diabetes mellitus en la provincia de Léon. Med Clin (Barc) 1992; 98: 607-611.
14. Tamayo B, Faure E, Roche MJ, Rubio E, Sánchez E, Salvador JA. Prevalence of diabetes and impaired glucose tolerance in Aragon, Spain. Diabetes Care 1997; 20: 534-536.
15. Segura A. Detección no es prevención. Med Clin (Barc) 1995; 105: 78.
16. Argimón JM, Fiol C, Pintó X, Hurtado I, Gracia V. Eficacia de la detección de la hipercolesterolemia en los individuos de más alto riesgo frente a la búsqueda oportunista. Med Clin (Barc) 1994; 102: 86-89.
17. Mur T, Franch J, Morató J, Mena A, Vilarrubias M. Llobera A. Macroangiopatia en la diabetes tipo II. El estudio Raval Sud. Aten Primaria 1995; 16: 67-72.
18. ADA Clinical Practice Recommendations. Position Statement. Screening for type 2 diabetes. Diabetes Care 1998 21 (Supl 1): S20-S22.
19. King H, Rewers M. WHO ad hoc Diabetes Reporting Group. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 1993; 16: 157-177.
20. Harris MI, Flegal KM, Eastman RC, Eberhardt MS, Cowie CC. Comparison of diabetes diagnostic categories in the US population according to 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care 1997; 20: 1859-1862.
21. Costa B, Monclús J. Llor JL, Gellida D, Garcia G, Cugat I et al y el Grup per a l'Estudi de la Diabetis a Tarragona. Diabetes y transtornos ignorados de la tolerancia a la glucosa en atencion primaria. Evidencia mediante detección oportunista. Aten Primaria 1995; 16: 532-537.
22. The DECODE Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 1988; 317: 371-375.
23. The DECODE Study Group. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetologia 1999; 42: 647-654.
24. Shaw JE, De Courten MP, Hodge AM, McCarty D, Gareboo H, Chitson P. IGT or IFG for predicting NIDDM. Who is right. WHO or ADA? Diabetes 1998: 47 (Supl 1): 150.
25. Costa A, Rios M, Fernandez M, Gomis R, Conget I. The 1997 ADA diabetes diagnostic categories: impact on employees' annual medical examination. Diabet Med 1999; 16: 529-529.
26. Shaw JE, Zimmet PZ, De Courten M, Dowse GK, Chitson P, Gareeboo H et al. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care 1999; 22: 399-402.
27. Vaccaro O, Ruffa G, Imperatore G, Iovino V, Rivellese AA, Ricardi G. Risk of diabetes in the new diagnostic category of IFG: a prospective analysis. Diabetes 1999; 22: 1490-1493.
28. 1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diabetes Care 1998; 21: 1221-1225.
29. Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus. An analysis using glycosylated hemoglobin levels. JAMA 1996; 276: 1246-1252.
30. Temple R, Clark PMS, Hales CN. Measurement of insulin secretion in type 2 diabetes: problems and pitfalls. Diabet Med 1994; 11: 432-436.
31. Moss SE, Klein R, Klein BEK, Meuer SM, The association of glycemia and cause-specific mortality in diabetic population. Arch Intern Med 1994; 154: 2473-2479.
32. Wingard DL, Scheidt-Nave C, Barret-Connor EL, McPhillips JB. Prevalence of cardiovascular and renal complications in older adults with normal or impaired glucose tolerance or NIDDM. Diabetes Care 1993; 16: 1022-1025.
33. Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kubota M et al. Asymptomatic hyperglycemia is associated with increased intimal plus medial thickness of the carotid artery. Diabetologia 1995; 38: 585-591.
34. Shaw JE, Hodge AM, De Courten M, Chitson P, Zimmet PZ. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 1999; 42: 1050-1054.
35. Nijpels G, Popp Snijders C, Kostense PJ, Bouter LM, Heine RJ. Cardiovascular risk factors prior to the development of non-insulin-dependent diabetes mellitus in persons with impaired glucose tolerance: the Hoorn Study. J Clin Epidemiol 1997; 50: 1003-1009.
36. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care 1999; 22: 920-924.
37. Balkau B, Shipley M, Jarret RJ, Pyorala K, Pyorala M, Forhan A et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. Diabetes Care 1998; 21: 360-367.
38. Donahue RP, Abbot RD, Reed DM, Yano K. Postchallenge glucose concentrations and coronary hearth disease in men of Japanese ancestry: Honolulu heart program. Diabetes 1987; 36: 689-692.
39. Costa B, Franch J, Martín F, Morató J, Donado A, Basera J et al, and IGT Research Group. Cardiovascular risk related to WHO/ADA diagnostic categories on high risk Spanish population Diabetologia 1999; 42 (Supl 1): A110.